Back
Novo Nordisk AS Stock Price Chart

Final Days: Should You Invest in This AI Startup Now?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Sell
32
NONOF
Novo Nordisk AS
Last Price:
$68.00
Seasonality Move:
8.3%
7 Day Trial
ALL ACCESS PASS
$
7

AI Marketing Shift Is Happening–Act Before It's Too Late!
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
Novo Nordisk AS Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 72.86 | Sell |
20-day SMA: | 78.68 | Sell |
50-day SMA: | 82.2 | Sell |
200-day SMA: | 110.91 | Sell |
8-day EMA: | 72.42 | Sell |
20-day EMA: | 76.93 | Sell |
50-day EMA: | 82.7 | Sell |
200-day EMA: | 101 | Sell |
Novo Nordisk AS Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.07 | Sell |
Relative Strength Index (14 RSI): | 30.02 | Sell |
Chaikin Money Flow: | 3597 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (73.33 - 88.69) | Sell |
Bollinger Bands (100): | (78.8 - 103.6) | Sell |
Novo Nordisk AS Technical Analysis
Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Novo Nordisk AS Stock
Is Novo Nordisk AS Stock a Buy?
-
Novo Nordisk AS share price is 68.96 while NONOF 8-day simple moving average is 72.86, which is a Sell signal.
-
The stock price of NONOF is 68.96 while Novo Nordisk AS 20-day SMA is 78.68, which makes it a Sell.
-
Novo Nordisk AS 50-day simple moving average is 82.20 while NONOF share price is 68.96, making it a Sell technically.
-
NONOF stock price is 68.96 and Novo Nordisk AS 200-day simple moving average is 110.91, creating a Sell signal.
NONOF Technical Analysis vs Fundamental Analysis
Sell
32
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy or a Sell?
-
Novo Nordisk AS stock is rated a SellThe current Novo Nordisk AS [NONOF] share price is $68.96. The Score for NONOF is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Novo Nordisk AS Stock Info
Market Cap:
306.1B
Price in USD:
68.96
Share Volume:
6.1K
Novo Nordisk AS 52-Week Range
52-Week High:
149.55
52-Week Low:
66.88
Sell
32
Novo Nordisk AS (NONOF)
is a Sell
Novo Nordisk AS Share Price Forecast
-
What is the Novo Nordisk AS stock price today?The Novo Nordisk AS stock price is 68.96 USD today.
-
Will NONOF stock go up or go down?Novo Nordisk AS> share price is forecast to RISE/FALL based on technical indicators
-
Is Novo Nordisk AS overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Novo Nordisk AS is overvalued.
Is Novo Nordisk AS Stock a Buy?
-
Novo Nordisk AS share price is 68.96 while NONOF 8-day exponential moving average is 72.42, which is a Sell signal.
-
The stock price of NONOF is 68.96 while Novo Nordisk AS 20-day EMA is 76.93, which makes it a Sell.
-
Novo Nordisk AS 50-day exponential moving average is 82.70 while NONOF share price is 68.96, making it a Sell technically.
-
NONOF stock price is 68.96 and Novo Nordisk AS 200-day simple moving average is 101.00, creating a Sell signal.
Fundamental Analysis of Novo Nordisk AS
Is Novo Nordisk AS a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Novo Nordisk AS
Should I short Novo Nordisk AS stock?
-
NONOF Moving Average Covergence Divergence (MACD) indicator is -4.07, suggesting Novo Nordisk AS is a Sell
-
Novo Nordisk AS Relative Strength Index (RSI) is 30.02, which suggest Novo Nordisk AS is oversold
-
The Bollinger Bands (25) for Novo Nordisk AS is (73.33 - 88.69), which suggest Novo Nordisk AS is a Sell
-
The Bollinger Bands (100) for Novo Nordisk AS is (78.8 - 103.6), which suggest Novo Nordisk AS is a Sell
* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.